Shingles Vaccine Market 2019-2025: Trends, Technology, Opportunities and forecasts by 2025

Shingles is known as Herpes Zoster which causes a blistering painful rash on the skin which lasts from 2 to 4 weeks. But, for some people, the pain may last for months or years. This pain is called as (PHN) Post Herpetic Neuralgia, which is a common complication of shingles and it’s occurrence increases with age.

Some of the players in global shingles vaccine market:
Merck& Co., Inc. (U.S.), GlaxoSmithKline plc (UK), Cipla Inc. (India), Pfizer Inc. (U.S.)

Increase in the prevalence and incidence of shingles disease around the world and increase in the global ageing population is expected to enhance the growth of shingles vaccine market across the globe. But, lack of awareness, high cost of the vaccination, unfavourable insurance coverage is major restraints of the global shingles vaccine market.

Read More @ https://www.medgadget.com/2021/01/shingles-vaccine-market-2019-2025-trends-technology-opportunities-and-forecasts-by-2025.html



Comments

Popular posts from this blog

Southeast Asia and Middle East Copper Wire and Cable Market: A Brief Evaluation of the Industry’s Prospects from 2023 to 2032

The Global Beacon Market: Exploring Its Emerging Trends and Investment Opportunities (2024-2032)

RFID Tags Market to Witness an Outstanding Growth during 2019-2026 – Honeywell, NXP Semiconductors, Alien Technology